PYCNOGENOL AND TRAUMATIC BRAIN INJURY

碧萝芷与脑外伤

基本信息

  • 批准号:
    7942792
  • 负责人:
  • 金额:
    $ 18.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a global health problem that is financially crippling for many families because of both specialized care and lost financial income. TBI involves at least two separate injury cascades that lead to neuronal and cognitive dysfunction. The secondary injury cascade may be amenable to pharmacologic intervention but the mechanisms are complicated requiring a multi-faceted approach. Oxidative stress, loss of mitochondrial function, and neuroinflammation appear to play major roles. Naturally occurring flavonoids are unique in possessing not only tremendous free radical scavenging properties but also the ability to modulate cellular homeostasis leading to a reduction in inflammation and cell toxicity. The proposed studies will investigate the idea that Pycnogenol(r) (PYC), a combination of bioflavonoids, can significantly reduce the secondary injury cascade following TBI. This is an extremely novel approach to TBI therapy since it utilizes a family of very closely related biologically active polyphenols derived from tree bark. The first series of studies will explore the best possible dosing of PYC to maximally reduce oxidative stress and neuroinflammation following experimental TBI in rodents. The second set of studies will explore the protective qualities of PYC on mitochondrial bioenergetics and cell survival in the hippocampus following experimental TBI. Successful completion of the studies will pave the way for using PYC in more involved experimental TBI studies and contribute to the development of a rational therapy leading to a more favorable outcome. PUBLIC HEALTH RELEVANCE: The proposed studies investigate a specialized compound, called a bioflavonoid, to determine if it can help protect cells in the brain following injury. Using a well characterized animal model of traumatic brain injury, subjects are treated with the compound, Pycnogenol(r), and tested for a variety of outcome measures. Bioflavonoids are known to manifest multiple different helpful properties such as reducing oxidative stress. If the studies work, then more complex and longer term studies can be proposed, hopefully leading to a more rational therapy for brain injury.
描述(由申请人提供):创伤性脑损伤(TBI)是一个全球性的健康问题,由于专业护理和经济收入损失,许多家庭在经济上陷入困境。TBI涉及至少两个独立的损伤级联,导致神经元和认知功能障碍。继发性损伤级联反应可能适合于药物干预,但其机制是复杂的,需要多方面的方法。氧化应激、线粒体功能丧失和神经炎症似乎起主要作用。天然存在的黄酮类化合物是独特的,不仅具有巨大的自由基清除性能,而且还具有调节细胞内稳态的能力,从而减少炎症和细胞毒性。拟议中的研究将调查碧萝芷(r)(PYC),一种双氯芬酸的组合,可以显着减少TBI后的继发性损伤级联反应的想法。这是一种非常新颖的TBI治疗方法,因为它利用了一个非常密切相关的生物活性多酚家族,这些多酚来源于树皮。第一系列研究将探索PYC的最佳剂量,以最大限度地减少啮齿动物实验性TBI后的氧化应激和神经炎症。第二组研究将探索PYC对实验性TBI后海马中线粒体生物能量学和细胞存活的保护质量。这些研究的成功完成将为PYC在更多涉及的实验性TBI研究中的应用铺平道路,并有助于开发一种合理的治疗方法,从而获得更有利的结果。 公共卫生关系:拟议中的研究调查了一种名为生物素的特殊化合物,以确定它是否可以帮助保护受伤后的大脑细胞。使用创伤性脑损伤的良好表征的动物模型,受试者用化合物碧萝芷治疗,并测试各种结果测量。众所周知,双歧杆菌具有多种不同的有益特性,如减少氧化应激。如果这些研究有效,那么可以提出更复杂和更长期的研究,希望能为脑损伤带来更合理的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN W SCHEFF其他文献

STEPHEN W SCHEFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN W SCHEFF', 18)}}的其他基金

CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL AD
临床前 AD 中细胞变化改变突触连接
  • 批准号:
    8665363
  • 财政年份:
    2013
  • 资助金额:
    $ 18.56万
  • 项目类别:
CELLULAR CHANGES ALTERING SYNAPTIC CONNECTIVITY IN PRECLINICAL AD
临床前 AD 中细胞变化改变突触连接
  • 批准号:
    8509203
  • 财政年份:
    2013
  • 资助金额:
    $ 18.56万
  • 项目类别:
SYNAPTIC CHANGE IN MILD COGNITIVE IMPAIRMENT
轻度认知障碍的突触变化
  • 批准号:
    7268814
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
SYNAPTIC CHANGE IN MILD COGNITIVE IMPAIRMENT
轻度认知障碍的突触变化
  • 批准号:
    7150089
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
SYNAPTIC CHANGE IN MILD COGNITIVE IMPAIRMENT
轻度认知障碍的突触变化
  • 批准号:
    7844859
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
SYNAPTIC CHANGE IN MILD COGNITIVE IMPAIRMENT
轻度认知障碍的突触变化
  • 批准号:
    7617169
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
SYNAPTIC CHANGE IN MILD COGNITIVE IMPAIRMENT
轻度认知障碍的突触变化
  • 批准号:
    7410039
  • 财政年份:
    2006
  • 资助金额:
    $ 18.56万
  • 项目类别:
Core--Animal surgery and TBI /SCI model
核心--动物外科与TBI/SCI模型
  • 批准号:
    7060631
  • 财政年份:
    2005
  • 资助金额:
    $ 18.56万
  • 项目类别:
RESPONSE OF THE AGING NERVOUS SYSTEM TO TRAUMA
老化神经系统对创伤的反应
  • 批准号:
    6922014
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:
RESPONSE OF THE AGING NERVOUS SYSTEM TO TRAUMA
老化神经系统对创伤的反应
  • 批准号:
    6595126
  • 财政年份:
    2003
  • 资助金额:
    $ 18.56万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 18.56万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了